Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cellular macromolecules involved in DNA damage and redox homeostasis refer to a broad and heterogeneous group of proteins, nucleic acids, and lipids that collectively maintain genomic integrity and balance reactive oxygen species (ROS) within the cell [Ray et al., 2012, Cell Signal]. This functional category includes critical DNA repair enzymes such as Poly (ADP-ribose) polymerase 1 (PARP1) and Ataxia-telangiectasia mutated (ATM), as well as master redox regulators like Nuclear factor erythroid 2-related factor 2 (NRF2) [Lord & Ashworth, 2012, Nature]. These molecules work in concert to detect chemical or radiation-induced lesions and initiate corrective signaling or antioxidant defenses to prevent mutations and cellular dysfunction [Sies, 2015, Redox Biol]. In many pathological states, such as cancer and neurodegeneration, the equilibrium between DNA damage and redox control is disrupted, leading to genomic instability or chronic oxidative damage [Hoeijmakers, 2009, N Engl J Med]. Therapeutic strategies targeting these systems often involve inhibiting repair mechanisms to induce synthetic lethality in tumors or activating protective pathways to mitigate oxidative stress in chronic diseases [Kansanen et al., 2013, Redox Biol]. Because this term describes a complex biological network rather than a single druggable entity, it is classified as a therapeutic area or category rather than a specific molecular target.
Modulation of DNA repair efficiency (e.g., PARP inhibition) or induction of antioxidant gene expression via the NRF2/KEAP1 pathway to alter cellular survival under stress.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cellular macromolecules involved in DNA damage and redox homeostasis.